Methadone treatment of injecting opioid users for prevention of HIV infection

Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL (2006)

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Gowing, LR; Farrell, M; Bornemann, ReinhardUniBi; Sullivan, LE; Ali, RL
Abstract / Bemerkung
OBJECTIVE: To assess the effects of oral substitution treatment for opioid-dependent injecting drug users on HIV risk behaviors and infections. DATA SOURCES: Multiple electronic databases were searched. Reference lists of retrieved articles were checked. METHODS: Because of varying methodologies of available studies, this systematic review was limited to a descriptive summary, looking at consistency of outcomes across studies. RESULTS: Twenty-eight studies involving methadone treatment were included in the review. Methadone maintenance treatment is associated with statistically significant reductions in injecting use and sharing of injecting equipment. It is also associated with reductions in numbers of injecting drug users reporting multiple sex partners or exchanges of sex for drugs or money, but has little effect on condom use. It appears that the reductions in risk behaviors do translate into fewer cases of HIV infection. CONCLUSIONS: Methadone maintenance treatment for injecting drug users significantly reduces the risk of transmission of HIV and should be provided as a component of a strategic approach to the prevention and control of HIV infection. There is insufficient evidence to determine whether other forms of oral substitution treatment also reduce the risk of HIV transmission.
opioid-related disorders; therapeutic use; methadone; prevention and control; drug therapy; intravenous; drug therapy; substance abuse; HIV infections
Page URI


Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE. 2006;21(2):193-195.
Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E., & Ali, R. L. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE, 21(2), 193-195.
Gowing, LR, Farrell, M, Bornemann, Reinhard, Sullivan, LE, and Ali, RL. 2006. “Methadone treatment of injecting opioid users for prevention of HIV infection”. JOURNAL OF GENERAL INTERNAL MEDICINE 21 (2): 193-195.
Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E., and Ali, R. L. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE 21, 193-195.
Gowing, L.R., et al., 2006. Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE, 21(2), p 193-195.
L.R. Gowing, et al., “Methadone treatment of injecting opioid users for prevention of HIV infection”, JOURNAL OF GENERAL INTERNAL MEDICINE, vol. 21, 2006, pp. 193-195.
Gowing, L.R., Farrell, M., Bornemann, R., Sullivan, L.E., Ali, R.L.: Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE. 21, 193-195 (2006).
Gowing, LR, Farrell, M, Bornemann, Reinhard, Sullivan, LE, and Ali, RL. “Methadone treatment of injecting opioid users for prevention of HIV infection”. JOURNAL OF GENERAL INTERNAL MEDICINE 21.2 (2006): 193-195.

44 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

An outbreak of HIV infection among people who inject drugs linked to injection of propofol in Taiwan.
Huang YC, Huang YF, Lin MH, Yang JY, Liao YH, Lo HY, Latkin C, Nelson KE., PLoS One 14(2), 2019
PMID: 30735511
Buprenorphine implants in medical treatment of opioid addiction.
Chavoustie S, Frost M, Snyder O, Owen J, Darwish M, Dammerman R, Sanjurjo V., Expert Rev Clin Pharmacol 10(8), 2017
PMID: 28571505
Sexual behaviors among methadone maintenance patients in a mountainous area in northern Vietnam.
Boggiano VL, Nguyen HLT, Nguyen LH, Tran TD, Van Nguyen H, Le HT, Le HQ, Hoang CD, Nguyen CT, Tran BX, Latkin CA, Zary N, Vu TMT., Subst Abuse Treat Prev Policy 12(1), 2017
PMID: 28841918
Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China.
Liu C, Liu PL, Dong QL, Luo L, Xu J, Zhou W, Wang X., Sci Rep 7(1), 2017
PMID: 28904357
Gender and Age Effects on the Trajectory of Depression in Opioid Users during Methadone Maintenance Treatment.
Wang PW, Lin HC, Yang YC, Hsu CY, Chung KS, Wu HC, Yen CF., Front Psychiatry 8(), 2017
PMID: 29321749
Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I, Mazhnaya A, Polonsky M, Marcus R, Bojko MJ, Filippovych S, Springer S, Dvoriak S, Altice FL., Drug Alcohol Depend 165(), 2016
PMID: 27370527
Abstinence at Successful Discharge in Publicly Funded Addiction Health Services.
Frimpong JA, Guerrero EG, Kong Y, Kim T., J Behav Health Serv Res 43(4), 2016
PMID: 26882909
The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment.
Bizzarri JV, Casetti V, Sanna L, Maremmani AG, Rovai L, Bacciardi S, Piacentino D, Conca A, Maremmani I., Ann Gen Psychiatry 15(), 2016
PMID: 27933094
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.
Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN, HPTN 058 Protocol Team., J Acquir Immune Defic Syndr 68(5), 2015
PMID: 25564105
Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users.
Sullivan SG, Wu Z, Cao X, Liu E, Detels R, National Methadone Maintenance Treatment Working Group., J Subst Abuse Treat 47(1), 2014
PMID: 24629884
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.
Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W., J Acquir Immune Defic Syndr 66(3), 2014
PMID: 24751432
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.
Nolan S, Dias Lima V, Fairbairn N, Kerr T, Montaner J, Grebely J, Wood E., Addiction 109(12), 2014
PMID: 25041346
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O'Connor PG., JAMA Intern Med 174(12), 2014
PMID: 25330017
Adherence to HIV treatment and care among previously homeless jail detainees.
Chen NE, Meyer JP, Avery AK, Draine J, Flanigan TP, Lincoln T, Spaulding AC, Springer SA, Altice FL., AIDS Behav 17(8), 2013
PMID: 22065234
Meta-analyses of seven of the National Institute on Drug Abuse's principles of drug addiction treatment.
Pearson FS, Prendergast ML, Podus D, Vazan P, Greenwell L, Hamilton Z., J Subst Abuse Treat 43(1), 2012
PMID: 22119178
HIV infection and risk of overdose: a systematic review and meta-analysis.
Green TC, McGowan SK, Yokell MA, Pouget ER, Rich JD., AIDS 26(4), 2012
PMID: 22112599
The cost of providing methadone maintenance treatment in Ontario, Canada.
Zaric GS, Brennan AW, Varenbut M, Daiter JM., Am J Drug Alcohol Abuse 38(6), 2012
PMID: 22783917
Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
Colom Farran J, Casas M, Pérez de Los Cobos J, Del Río M, Roncero C, Castells X, Valero S, Eiroa-Orosa FJ, Batlle F, Trujols J., Eur Addict Res 18(6), 2012
PMID: 22854605
Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.
Wilson ME, Kinlock TW, Gordon MS, O'Grady KE, Schwartz RP., Am J Addict 21(5), 2012
PMID: 22882399
HIV risks and seroprevalence among Mexican American injection drug users in California.
Martinez AN, Bluthenthal RN, Flynn NM, Anderson RL, Kral AH., AIDS Behav 15(1), 2011
PMID: 20020194
The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.
Yang J, Oviedo-Joekes E, Christian KW, Li K, Louie M, Schechter M, Spittal P., Drug Alcohol Rev 30(6), 2011
PMID: 21355933
Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.
Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL., Drug Alcohol Depend 116(1-3), 2011
PMID: 21232882
Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.
Yokell MA, Zaller ND, Green TC, Rich JD., Curr Drug Abuse Rev 4(1), 2011
PMID: 21466501
Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan.
Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, Chuang P, Shih CY, Chou YC, Liu YL., Subst Abuse Treat Prev Policy 6(), 2011
PMID: 21473789
Can drug users be effective change agents? Yes, but much still needs to change.
Dickson-Gomez J., Subst Use Misuse 45(1-2), 2010
PMID: 20025444
Impact of interim methadone maintenance on HIV risk behaviors.
Wilson ME, Schwartz RP, O'Grady KE, Jaffe JH., J Urban Health 87(4), 2010
PMID: 20386992
Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.
Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, Robertson JR., BMJ 341(), 2010
PMID: 20595255
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.
Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE., J Acquir Immune Defic Syndr 55(1), 2010
PMID: 20393347
Drug treatment as HIV prevention: expanding treatment options.
Metzger DS, Zhang Y., Curr HIV/AIDS Rep 7(4), 2010
PMID: 20803321
Drug treatment as HIV prevention: a research update.
Metzger DS, Woody GE, O'Brien CP., J Acquir Immune Defic Syndr 55 Suppl 1(), 2010
PMID: 21045597
The effect of methadone maintenance on positive outcomes for opiate injection drug users.
Corsi KF, Lehman WK, Booth RE., J Subst Abuse Treat 37(2), 2009
PMID: 19150202
Opioid dependence treatment: options in pharmacotherapy.
Stotts AL, Dodrill CL, Kosten TR., Expert Opin Pharmacother 10(11), 2009
PMID: 19538000
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.
Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA., J Subst Abuse Treat 35(1), 2008
PMID: 17933486

29 References

Daten bereitgestellt von Europe PubMed Central.

Substitution treatment of injecting opioid users for prevention of HIV infection [Cochrane Review]
Gowing L, Farrell M, Bornemann R, Ali R., 2004
HIV/AIDS Surveillance Report
A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.
Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD., Drug Alcohol Depend 72(1), 2003
PMID: 14563543
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM., JAMA 283(10), 2000
PMID: 10714729
Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
Camacho LM, Bartholomew NG, Joe GW, Cloud MA, Simpson DD., Drug Alcohol Depend 41(1), 1996
PMID: 8793304
Gender differences at admission and follow-up in a sample of methadone maintenance clients.
Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD., Subst Use Misuse 34(8), 1999
PMID: 10359226
Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.
King VL, Kidorf MS, Stoller KB, Brooner RK., J Addict Dis 19(4), 2000
PMID: 11110066
Changes in cocaine use after entry to methadone treatment.
Magura S, Siddiqi Q, Freeman RC, Lipton DS., J Addict Dis 10(4), 1991
PMID: 1777498
HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report.
Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P., NIDA Res. Monogr. 95(), 1989
PMID: 2641010
Drug abuse treatment success among needle exchange participants.
Brooner R, Kidorf M, King V, Beilenson P, Svikis D, Vlahov D., Public Health Rep 113 Suppl 1(), 1998
PMID: 9722818
Methadone maintenance as HIV risk reduction with street-recruited injecting drug users.
Kwiatkowski CF, Booth RE., J. Acquir. Immune Defic. Syndr. 26(5), 2001
PMID: 11391170
Client engagement and change during drug abuse treatment.
Simpson DD, Joe GW, Rowan-Szal G, Greener J., J Subst Abuse 7(1), 1995
PMID: 7655308
Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, Stewart D, Welch S., Addiction 95(11), 2000
PMID: 11219367
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.
Meandzija B, O'Connor PG, Fitzgerald B, Rounsaville BJ, Kosten TR., Drug Alcohol Depend 36(2), 1994
PMID: 7851277
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, DePhilippis D, Stolley P, Abrutyn E., J. Acquir. Immune Defic. Syndr. 6(9), 1993
PMID: 8340896
What happens when a demonstration project ends. Consequences for a clinic and its clients.
Grella CE, Anglin MD, Rawson R, Crowley R, Hasson A., J Subst Abuse Treat 13(3), 1996
PMID: 9017568
A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.
Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J., Health Psychol 22(2), 2003
PMID: 12683743
Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
Stark K, Muller R, Bienzle U, Guggenmoos-Holzmann I., J Epidemiol Community Health 50(5), 1996
PMID: 8944860
Community reinforcement approach in the treatment of opiate addicts.
Abbott PJ, Weller SB, Delaney HD, Moore BA., Am J Drug Alcohol Abuse 24(1), 1998
PMID: 9513627
Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, Cooney NL, Rosenheck RA, Li SH, Kosten TR., Am J Psychiatry 156(1), 1999
PMID: 9892294
HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.
Moss AR, Vranizan K, Gorter R, Bacchetti P, Watters J, Osmond D., AIDS 8(2), 1994
PMID: 8043227
Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
Williams AB, McNelly EA, Williams AE, D'Aquila RT., AIDS Care 4(1), 1992
PMID: 1314099
Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
Serpelloni G, Carrieri MP, Rezza G, Morganti S, Gomma M, Binkin N., AIDS Care 6(2), 1994
PMID: 8061081
Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
Marsch LA, Bickel WK, Badger GJ, Jacobs EA., Drug Alcohol Depend 77(2), 2005
PMID: 15664721
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick RP, Breen C, Kimber J, Davoli M., 2002
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Mattick RP, Kimber J, Breen C, Davoli M., Cochrane Database Syst Rev (2), 2003
PMID: 12804429

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 16336624
PubMed | Europe PMC

Suchen in

Google Scholar